Method for fabricating a thick copper line and copper inductor resulting therefrom
    61.
    发明授权
    Method for fabricating a thick copper line and copper inductor resulting therefrom 有权
    用于制造由其产生的粗铜线和铜电感器的方法

    公开(公告)号:US07776705B2

    公开(公告)日:2010-08-17

    申请号:US11470552

    申请日:2006-09-06

    Abstract: A method of forming one or more inductors on a substrate is disclosed. The method includes forming a first dielectric material over the substrate, forming a trench in the first dielectric material, and substantially filling the trench with copper to form the one or more inductors. The first dielectric material is removed and a second dielectric material is formed over the copper. The second dielectric material is removed from an uppermost portion of the copper, thus leaving a portion of the second dielectric material on the sidewalls of the copper.

    Abstract translation: 公开了一种在衬底上形成一个或多个电感器的方法。 该方法包括在衬底上形成第一介电材料,在第一介电材料中形成沟槽,并用铜基本上填充沟槽以形成一个或多个电感器。 去除第一电介质材料,并在铜上形成第二电介质材料。 第二电介质材料从铜的最上部去除,因此在铜的侧壁上留下一部分第二电介质材料。

    PEPTIDE IMAGING AGENTS
    62.
    发明申请
    PEPTIDE IMAGING AGENTS 有权
    肽成像剂

    公开(公告)号:US20100150843A1

    公开(公告)日:2010-06-17

    申请号:US12600265

    申请日:2008-05-16

    CPC classification number: A61K49/0056 A61B5/0071 A61B5/4842 A61K49/0032

    Abstract: The present invention relates to labelled cMet binding peptides suitable for optical imaging in vivo. The peptides are labelled with an optical reporter group suitable for imaging in the red to near-infrared region. Also disclosed are pharmaceutical compositions and kits, as well as in vivo imaging methods, especially of use in the detection, staging, diagnosis, monitoring of disease progression or monitoring of treatment of colorectal cancer (CRC).

    Abstract translation: 本发明涉及适用于体内光学成像的标记的cMet结合肽。 肽用适于在红色至近红外区域成像的光学报告基团标记。 还公开了药物组合物和试剂盒,以及体内成像方法,特别是用于检测,分期,诊断,监测疾病进展或监测结肠直肠癌(CRC)的治疗。

    METHODS AND COMPOSITIONS FOR WET ETCHING
    66.
    发明申请
    METHODS AND COMPOSITIONS FOR WET ETCHING 审中-公开
    湿蚀刻的方法和组合

    公开(公告)号:US20080041813A1

    公开(公告)日:2008-02-21

    申请号:US11618240

    申请日:2006-12-29

    Abstract: A composition comprising an aqueous solution of: a wet-etch formulation that is proven to etch copper; and a wetting agent. Exemplary wet-etch formulations include a mixture of a strong inorganic acid, such as sulfuric acid or hydrofluoric acid, and an oxidizing agent such as hydrogen peroxide, and further include ammonium persulfate. Exemplary wetting agents include organic acids such as citric acid, acetic acid, oxalic acid, or formic acid. Processes of using the compositions for wet-etching, or chemical mechanical polishing, or fabricating thick copper inductors, are further provided.

    Abstract translation: 一种组合物,其包含以下溶液:水蚀刻制剂,被证明可蚀刻铜; 和润湿剂。 示例性的湿蚀刻制剂包括强无机酸(例如硫酸或氢氟酸)和氧化剂如过氧化氢的混合物,并且还包括过硫酸铵。 示例性的润湿剂包括有机酸如柠檬酸,乙酸,草酸或甲酸。 还提供了使用组合物进行湿蚀刻或化学机械抛光或制造厚铜电感器的方法。

    Contrast agents
    67.
    发明授权
    Contrast agents 失效
    对比剂

    公开(公告)号:US07182934B2

    公开(公告)日:2007-02-27

    申请号:US11108598

    申请日:2005-04-18

    Abstract: The invention provides a composition of matter of formula I V-L-R   (I) where V is an organic group having binding affinity for an angiotensin II receptor site, L is a linker moiety or a bond, and R is a moiety detectable in in vivo imaging of a human or animal body, with the provisos that where V is angiotensin or a peptidic angiotensin derivative or analog then V-L-R is other than a non-metal radionuclide substituted peptide (eg 125I substituted angiotensin II) and L-V is other than simply a peptide with a chelating agent amide bonded to a side chain thereof. This composition of matter may be used to image cardiovascular diseases and disorders.

    Abstract translation: 本发明提供式I的物质的组成<?in-line-formula description =“In-line Formulas”end =“lead”?> VLR(I)<?in-line-formula description =“In-Line Formulas “end =”tail“?>其中V是对血管紧张素II受体位点具有结合亲和力的有机基团,L是连接体部分或键,R是在体内成像人或动物体中可检测的部分, 条件是其中V是血管紧张素或肽血管紧张素衍生物或类似物,则VLR不是非金属放射性核素取代肽(例如,125 I取代的血管紧张素II),而LV不仅仅是一种肽 与其侧链结合的螯合剂酰胺。 这种物质的组成可以用于影像心血管疾病和病症。

Patent Agency Ranking